Royalty Pharma plc

RPRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001802768

Price chart

Open-market purchases and sales by RPRX insiders, newest first.

Insider trades
Filed (ET)Trade dateInsiderTransactionSharesAvg priceValueShares afterHolding changeFiling
Sep 24, 20264:10 PM ETSep 22, 2026Hite ChristopherEVP & Chairman, PartneringSSaleClass A Ordinary Shares−100K$58.531−$5.85M270.4K−27.0%SEC10b5-1
Aug 19, 20264:20 PM ETAug 18, 2026Hite ChristopherEVP & Chairman, PartneringSSaleClass A Ordinary Shares−100K$59.9725−$6M370.4K−21.3%SEC10b5-1
Aug 17, 20265:01 PM ETAug 13, 2026Coyne Terrance P.EVP & CFOSSaleClass A Ordinary Shares−11K$58.6758−$645.55K0−100.0%SEC10b5-1
Jul 2, 20264:10 PM ETJul 1, 2026Urist MarshallEVP, Research & InvestmentsSSaleClass A Ordinary Shares−9.1K$55.8802−$508.45K0−100.0%SEC10b5-1
Jul 2, 20264:08 PM ETJun 30, 2026Hite ChristopherEVP & Chairman, PartneringSSaleClass A Ordinary Shares−100K$56.5181−$5.65M459.4K−17.9%SEC10b5-1

The largest institutional positions in RPRX at the end of Q2 2026.

Institutions holding RPRX in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
MORGAN STANLEY42,931,597$2.41B0.13%−640,036−1.5%Reduced
Capital International Investors35,273,770$1.98B0.41%+268,034+0.8%Added
BlackRock, Inc.27,832,977$1.56B0.02%+1,925,232+7.4%Added
FMR LLC24,513,814$1.37B0.06%−638,428−2.5%Reduced
STATE STREET CORP12,338,229$691.8M0.02%+1,348,378+12.3%Added